Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)
4.97 -0.06 (-1.19%) 11:06 ET [NASDAQ]
4.90 x 100 4.98 x 100
Realtime by (Cboe BZX)
4.90 x 100 4.98 x 100
Realtime 4.93 -0.10 (-1.99%) 09:30 ET
Quote Overview for Thu, Apr 3rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.86
Day High
5.16
Open 4.99
Previous Close 5.03 5.03
Volume 66,027 66,027
Avg Vol 523,274 523,274
Stochastic %K 82.21% 82.21%
Weighted Alpha -65.83 -65.83
5-Day Change +1.25 (+32.85%) +1.25 (+32.85%)
52-Week Range 3.56 - 28.60 3.56 - 28.60
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,244
  • Shares Outstanding, K 9,790
  • Annual Sales, $ 83,810 K
  • Annual Income, $ -240,720 K
  • EBIT $ -270 M
  • EBITDA $ -209 M
  • 60-Month Beta 0.41
  • Price/Sales 0.00
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 72.75% ( -12.08%)
  • Historical Volatility 173.47%
  • IV Percentile 7%
  • IV Rank 8.75%
  • IV High 697.81% on 10/14/24
  • IV Low 12.81% on 12/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 216
  • Volume Avg (30-Day) 853
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 94,724
  • Open Int (30-Day) 90,419

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -3.60
  • Number of Estimates 1
  • High Estimate -3.60
  • Low Estimate -3.60
  • Prior Year -7.20
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.65 +37.95%
on 03/27/25
Period Open: 3.88
5.42 -7.10%
on 03/31/25
+1.16 (+29.77%)
since 03/03/25
3-Month
3.56 +41.44%
on 02/24/25
Period Open: 9.18
10.28 -51.00%
on 01/06/25
-4.14 (-45.15%)
since 01/03/25
52-Week
3.56 +41.44%
on 02/24/25
Period Open: 23.60
28.60 -82.39%
on 07/16/24
-18.56 (-78.66%)
since 04/03/24

Most Recent Stories

More News
Stocks Set to Open Sharply Lower as Tariff Worries Sour Risk Sentiment, U.S. Jobs Data and Powell’s Remarks Awaited

June S&P 500 E-Mini futures (ESM25) are down -1.01%, and June Nasdaq 100 E-Mini futures (NQM25) are down -1.21% this morning as risk sentiment took a hit ahead of U.S. President Donald Trump’s deadline...

GOOGL : 151.13 (-3.76%)
NVDA : 102.61 (-7.07%)
PVH : 67.26 (-13.58%)
OXM : 54.69 (-10.20%)
BLUE : 4.97 (-1.19%)
WRB : 70.21 (+0.66%)
ABF.LN : 1,989.000 (+1.48%)
CAG : 26.99 (+2.31%)
LW : 57.76 (+6.67%)
ESM25 : 5,464.75 (-4.33%)
LULU : 245.30 (-13.24%)
COOP : 132.11 (-1.09%)
Bluebird: Q3 Earnings Snapshot

Bluebird: Q3 Earnings Snapshot

BLUE : 4.97 (-1.19%)
Bluebird: Q2 Earnings Snapshot

Bluebird: Q2 Earnings Snapshot

BLUE : 4.97 (-1.19%)
Bluebird: Q1 Earnings Snapshot

Bluebird: Q1 Earnings Snapshot

BLUE : 4.97 (-1.19%)
Is Bluebird Bio Stock a Buy?

It won't be easy for the company to bounce back.

BLUE : 4.97 (-1.19%)
Is Bluebird Bio Stock a Buy?

This small biotech is struggling to fly -- and investors should probably steer clear.

BLUE : 4.97 (-1.19%)
Better Buy: Bluebird Bio Vs. Novavax

Who wins this face-to-face between two beaten-down biotechs?

BLUE : 4.97 (-1.19%)
NVAX : 5.50 (-8.03%)
Is This Beaten-Down Stock a Good Acquisition Target?

This company has proven its innovative abilities, but that's not enough to outperform the market.

BLUE : 4.97 (-1.19%)
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst

Biotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.

WFC : 66.03 (-8.62%)
BLUE : 4.97 (-1.19%)
Why Bluebird Bio Stock Flew Higher Than the Market Today

The company was thrown a financial lifeline.

HTGC : 18.38 (-3.57%)
BLUE : 4.97 (-1.19%)
Is Bluebird Bio Stock a Buy Now?

Are you feeling brave?

BLUE : 4.97 (-1.19%)
Why Bluebird Bio Stock Dived Into the Red on Tuesday

The biotech has had a tough time of it over the past few years; a pundit's revised take on the company won't improve that situation.

HSBC : 53.84 (-7.12%)
BLUE : 4.97 (-1.19%)
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today

The answer hardly inspires confidence.

BLUE : 4.97 (-1.19%)
2 Red Flags for Bluebird Bio Stock

The biotech's struggles may continue.

VRTX : 482.95 (-0.11%)
CRSP : 32.26 (-5.64%)
BLUE : 4.97 (-1.19%)
Better Risky Investment: Bluebird Bio vs. Shiba Inu

Few investors dare to tread where the ice is known to be very thin.

CRSP : 32.26 (-5.64%)
BLUE : 4.97 (-1.19%)
Should You Invest in Bluebird Bio Right Now?

After two December share price crashes, there's no evident cure for Bluebird Bio's ills.

BLUE : 4.97 (-1.19%)
If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have Today

Can things get better for this struggling stock?

BLUE : 4.97 (-1.19%)
1 Green Flag and 1 Red Flag for Bluebird Bio Stock

The stock has been in the news lately.

VRTX : 482.95 (-0.11%)
CRSP : 32.26 (-5.64%)
BLUE : 4.97 (-1.19%)
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024

Doing a little math and doing a little extra research can make a big difference.

BLUE : 4.97 (-1.19%)
CRSP : 32.26 (-5.64%)
Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?

The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.

CRSP : 32.26 (-5.64%)
VRTX : 482.95 (-0.11%)
BLUE : 4.97 (-1.19%)

Business Summary

bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic...

See More

Key Turning Points

3rd Resistance Point 5.94
2nd Resistance Point 5.68
1st Resistance Point 5.35
Last Price 4.97
1st Support Level 4.76
2nd Support Level 4.50
3rd Support Level 4.17

See More

52-Week High 28.60
Fibonacci 61.8% 19.03
Fibonacci 50% 16.08
Fibonacci 38.2% 13.13
Last Price 4.97
52-Week Low 3.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades